Skip to main content
. Author manuscript; available in PMC: 2009 Oct 19.
Published in final edited form as: Ann Intern Med. 2009 May 5;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006

Table 3. Comparison of Performance of CKD-EPI and MDRD Study Equations in the Validation Dataset.

Variable and Equation All Patients Patients with estimated GFR <60 ml/min/1.73 m2 Patients with estimated GFR ≥60 ml/min/1.73 m2
Median difference (95% CI), mL/min per 1.73 m2
CKD-EPI 2.5 (2.1 - 2.9) 2.1 (1.7 - 2.4) 3.5 (2.6 - 4.5)
MDRD Study 5.5 (5.0 - 5.9) 3.4 (2.9 - 4.0) 10.6 (9.8 - 11.3)
Interquartile range for differences (95% CI) - mL/min per 1.73 m2
CKD-EPI 16.6 (15.9 - 17.3) 11.3 (10.7 - 12.1) 24.2 (22.8 - 25.3)
MDRD Study 18.3 (17.4 - 19.3) 12.9 (12.0 - 13.6) 25.7 (24.4 - 27.1)
P30 (95% CI) - %§
CKD-EPI 84.1 (83.0 - 85.3) 79.9 (78.1 - 81.7) 88.3 (86.9 - 89.7)
MDRD Study 80.6 (79.5 - 82.0) 77.2 (75.5 - 79.0) 84.7 (83.0 - 86.3)
Root mean square error (95% CI)
CKD-EPI 0.250 (0.241 - 0.259) 0.284 (0.270 - 0.298) 0.213 (0.203 - 0.223)
MDRD Study 0.274 (0.265 - 0.283) 0.294 (0.280 - 0.308) 0.248 (0.238 - 0.258)

CKD-EPI = Chronic Kidney Disease Epidemiology Collaboration; GFR = glomerular filtration rate; MDRD = Modification of Diet in Renal Disease.

*

To convert GFR from mL/min per 1.73 m2 to mL/s per 1.73 m2, multiply by 0.0167.

Median difference refers to measured GFR minus estimated GFR.

Interquartile range refers to the 25–75th percentile.

§

P30 refers to percentage of GFR estimates that are within 30% of measured GFR.